Cardiovascular Care Across the Cancer Continuum by Dr. Anju Nohria, MD

YOUR SPEAKER

Dr. Anju Nohria, MD
Director of the Cardio-Oncology Program, NYU Langone Health · Founding member of The Survivorship Society

WHY THIS SESSION

Cardiovascular disease is one of the leading causes of illness and death among cancer survivors, and many of the patients we follow carry the risk long after treatment ends. In this session, Dr. Nohria walks through cardiovascular care at every stage of the cancer journey: assessing risk before therapy, recognizing cardiotoxicity during treatment, and managing blood pressure, lipids, glucose and lifestyle in survivorship.

WHAT YOU WILL TAKE AWAY

1. Why heart disease and cancer share so many risk factors, and why cardiovascular disease weighs so heavily on long-term survivors.
2. Who needs a cardiovascular risk assessment before cancer therapy begins.
3. The cardiotoxicity of common therapies, and the early signs worth watching for in clinic.
4. How managing blood pressure, lipids, glucose and activity during and after treatment may shape both heart and cancer outcomes.
5. When to bring cardio-oncology into a patient's care.

WHO THIS IS FOR

• Internists and primary care physicians who follow cancer survivors
• Oncology teams and cardiologists
• Nurse practitioners and mental health providers caring for people with cancer and their families

THE SESSION

Monday, November 16, 2026 · 6:00 PM ET · Online on Zoom
45 minute talk followed by live Q&A, hosted by Dr. Guy Maytal, co-founder of The Survivorship Society.